Moderna CEO Stéphane Bancel deflected concerns about the new presidential administration's potential impact on life sciences ...
A Boston developer won planning-board approval for his third office-to-housing conversion under a city tax-break program.
Moderna Inc.’s stock erased early losses to gain 3.4% on Friday, after the biotech company posted a wider-than-expected ...
The biotech giant reported a bigger-than-expected quarterly loss. Finance chief James Mock attributed the loss to a scale down.
Moderna Inc. recorded another quarterly loss as vaccine sales wane and the company had an unexpected charge for a canceled ...
Investors were digesting a busy week of tariff hikes and inflation updates, as fresh retail data and earnings reports rolled ...
Investors were digesting a busy week of tariff hikes and inflation updates, as fresh retail data and earnings reports rolled ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results